KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginFCF Payout RatioGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Lam Research (LRCX) EBT Margin: 2009-2025

Historic EBT Margin for Lam Research (LRCX) over the last 17 years, with FY2025 value amounting to 32.32%.

  • Lam Research's EBT Margin rose 38700.0% to 34.92% in Q3 2025 from the same period last year, while for Sep 2025 it was 33.29%, marking a year-over-year increase of 36100.0%. This contributed to the annual value of 32.32% for FY2025, which is 30700.0% up from last year.
  • Per Lam Research's latest filing, its EBT Margin stood at 32.32% for FY2025, which was up 30700.0% from 29.25% recorded in FY2024.
  • Lam Research's EBT Margin's 5-year high stood at 32.32% during FY2025, with a 5-year trough of 29.25% in FY2024.
  • Its 5-year average for EBT Margin is 30.18%, with a median of 29.88% in 2021.
  • Its EBT Margin has fluctuated over the past 5 years, first surged by 42500bps in 2021, then crashed by -8300bps in 2023.
  • Lam Research's EBT Margin (Annual) stood at 29.88% in 2021, then grew by 1bps to 30.15% in 2022, then dropped by -3bps to 29.32% in 2023, then fell by 0bps to 29.25% in 2024, then grew by 10bps to 32.32% in 2025.
  • Its EBT Margin stands at 32.32% for FY2025, versus 29.25% for FY2024 and 29.32% for FY2023.